Forma Therapeutics Holdings Inc
NASDAQ:FMTX
Forma Therapeutics Holdings Inc
Accumulated Depreciation
Forma Therapeutics Holdings Inc
Accumulated Depreciation Peer Comparison
Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors
Company | Accumulated Depreciation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Forma Therapeutics Holdings Inc
NASDAQ:FMTX
|
Accumulated Depreciation
-$4.8m
|
CAGR 3-Years
35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Accumulated Depreciation
-$6.7B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-4%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Forma Therapeutics Holdings Inc's Accumulated Depreciation?
Accumulated Depreciation
-4.8m
USD
Based on the financial report for Dec 31, 2021, Forma Therapeutics Holdings Inc's Accumulated Depreciation amounts to -4.8m USD.
What is Forma Therapeutics Holdings Inc's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 3Y
35%
Over the last year, the Accumulated Depreciation growth was 59%. The average annual Accumulated Depreciation growth rates for Forma Therapeutics Holdings Inc have been 35% over the past three years .